Literature DB >> 11970881

Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection.

Jody L Baron1, Leon Gardiner, Stephen Nishimura, Kanade Shinkai, Richard Locksley, Don Ganem.   

Abstract

NKT cells are specialized cells of the immune system that bear both T cell and NK cell markers. Classical NKT cells display TCRs of restricted heterogeneity (Valpha14-Jalpha281) and recognize lipid antigens (e.g., alpha-galactosyl ceramide) presented by nonpolymorphic CD1 molecules. Recently, other nonclassical NKT subsets have been recognized, including NKT cells not reactive with CD1d-alpha-galactosyl ceramide complexes. The biological functions of these cells are unknown. Here, we show that nonclassical NKT cells that are CD1d restricted but nonreactive to alpha-GalCer are activated in response to hepatocytes expressing hepatitis B viral antigens in a transgenic mouse model of acute hepatitis B virus infection. Our results document the first in vivo function for such nonclassical NKT cells and suggest a role for these cells in the host response to HBV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11970881     DOI: 10.1016/s1074-7613(02)00305-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  88 in total

1.  MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.

Authors:  Markus Sköld; Martin Stenström; Stephane Sidobre; Petter Höglund; Mitchell Kronenberg; Susanna Cardell
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

Review 2.  Role of CD1d-restricted NKT cells in microbial immunity.

Authors:  Markus Sköld; Samuel M Behar
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  NKT cells--an early warning system for HBV infection.

Authors:  Dale I Godfrey; Adam P Uldrich; Alan G Baxter
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

4.  Regulation of CD1d expression and function by a herpesvirus infection.

Authors:  David Jesse Sanchez; Jenny E Gumperz; Don Ganem
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 5.  V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes.

Authors:  Yuki Kinjo; Mitchell Kronenberg
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

6.  Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model.

Authors:  I-Tsu Chyuan; Hwei-Fang Tsai; Horng-Tay Tzeng; Chi-Chang Sung; Chien-Sheng Wu; Pei-Jer Chen; Ping-Ning Hsu
Journal:  Cell Mol Immunol       Date:  2015-02-09       Impact factor: 11.530

Review 7.  Evolutionary struggles between NK cells and viruses.

Authors:  Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

8.  Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus.

Authors:  Sílvia Vilarinho; Kouetsu Ogasawara; Stephen Nishimura; Lewis L Lanier; Jody L Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

9.  Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation.

Authors:  Shiny Nair; Chandra Sekhar Boddupalli; Rakesh Verma; Jun Liu; Ruhua Yang; Gregory M Pastores; Pramod K Mistry; Madhav V Dhodapkar
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

10.  Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.

Authors:  Robyn Puro; Robert J Schneider
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.